A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1999

Primary Completion Date

July 31, 2001

Conditions
Primary or Secondary Antibody Deficiency
Interventions
BIOLOGICAL

Vigam® (Human Normal Immunoglobulin)

Trial Locations (8)

Unknown

Papworth Hospital, Papworth Everard

Cardiff Royal Infirmary, Cardiff

Leicester Royal Infirmary, Leicester

Royal Brompton Hospital, London

Royal Free Hospital, London

Royal Victoria Infirmary, Newcastle

Hospital of St Cross, Rugby

Taunton & Somerset Hospital, Somerset

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER